XML 23 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Additional Information to the Items of Profit or Loss (Tables)
 6 Months Ended
Jun. 30, 2021
Disclosure of additional information [text block] [Abstract]  
Schedule of additional information to the items of profit or loss
   Six months ended
June 30,		   Year Ended
December 31,		 
   2021   2020   2020 
   Unaudited   Audited 
   USD in thousands 
a. Research and development expenses:            
             
Wages and related expenses  $183   $181   $322 
Share-based payment   17    100    69 
Clinical studies   49    1    - 
Regulatory, professional and other expenses   322    178    119 
Research and preclinical studies   142    33    139 
Chemistry and formulations   249    -    - 
                
    962    493    649 
                
b. General and administrative expenses:               
                
Wages and related expenses   99    106    237 
Share-based payment   7    69    22 
Professional and directors’ fees   884    679    1,283 
Business development expenses   -    5    58 
Office maintenance, rent and other expenses   55    53    182 
Investor relations and business expenses   562    7    22 
Regulatory expenses   58    51    98 
                
   $1,665   $970    1,902